Member Info for Timster

Thank goodness...

This COVID play just woke up!

A myth!!! It's never failed....

Personally it M waiting for sujood to confirm news.

Can't buy a bean on HL

Someone knows something...

Hope Al had stood medusa down!!

It'll only take a few weeks to develop an affimer to detect it, we'll sell all we can make........

Well into Q1 🤣🤣🤣🤣

3rd Jan you moron

I'm amazed your strong BUY rec didn't bring in the punters.

As always, as fun as the guessing games are just wait for an RNS.

It could surprise us all and be something completely random.

More importantly when's the CFO announcement coming???

RNS tomorrow, big start to 2025 🎇

NY size buyer

Don't panic BV, companies house is public sector 10 days is an incredibly quick turn around for changing the nature of business on a web form.

TARGET PRICE?

It means there's a massive Christmas RNS tomorrow 🎉🎉🎉🎉

Back to the real world it will make feck all difference to the SP.

Happy Christmas all!

Is it us?

Lda why do you think anyone here will come up with a better number then you could, perhaps try looking at slide 40. I'm going to say a year.

How much do you think BITL?

Agreed, yesterday's "update" wasn't an update it's just the trials website catching up with what the last RNS said.

Nice work, maybe the 3 amigos can have a day off so the board isn't just pure green.

The SAB CJ!!! Don't make me laugh Dr tap and this bunch of clowns they wouldn't have a clue:

Robin Jones, MBBS, MRCPD, MD, Professor and Group Leader in Sarcoma Clinical Trials at The Institute of Cancer Research and the Royal Marsden Hospital in London.

Lee Cranmer, MD, PhD, Head of Sarcoma Oncology at the University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington.

Robert Metcalf, MBChB MRCP PhD, Clinician Scientist in Experimental Cancer Medicine and Honorary Consultant in Head and Neck Cancer Oncology and Salivary Gland Cancer Expert at the Christie NHS Foundation Trust, Manchester.

Alan Ho, MD, PhD, Clinician-Scientist and translational clinical researcher on the head/neck medical oncology service at Memorial Sloan Kettering Cancer Center, New York City.

Andrea Napolitano, D., PhD. Consultant Oncologist and Experimental Therapeutics Expert at the Institute for Cancer Research and Royal Marsden Hospital, London.

Anthony Yu, MD, MS, Clinical Onco-Cardiologist specializing in the management of cardio-toxicities of approved and experimental therapeutics, Memorial Sloan Kettering Cancer Center, New York City.